Regaloside C is primarily studied for its potential anti-inflammatory and immunomodulatory effects. It has shown activity in suppressing pro-inflammatory cytokines, making it a candidate for research in chronic inflammatory diseases. Additionally, Regaloside C exhibits antioxidant properties, which may contribute to cellular protection against oxidative stress. It is also being explored for its role in neuroprotection, with early studies suggesting it might help in delaying neurodegenerative processes. Due to its natural origin and bioactive profile, it is used in preclinical studies focusing on drug development for metabolic and age-related disorders.